Anne E. Gill

Evolution of high-level resistance during low-level antibiotic exposure

Antibiotics bioremediation: Perspectives on its ecotoxicity and resistance

Efflux-mediated multiresistance in Gram-negative bacteria

Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology

Practical applications and feasibility of efflux pump inhibitors in the clinic—A vision for applied use

A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future

Cationic antiseptics: diversity of action under a common epithet

Acinetobacter baumannii : Emergence of a Successful Pathogen

Three Decades of β-Lactamase Inhibitors

Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update

The Contribution of a Novel Ribosomal S12 Mutation to Aminoglycoside Resistance ofEscherichia coliMutants

Novel targets for antibiotic drug design.